Ambrisentan therapy in patients with pulmonary arterial hypertension who discontinued bosentan or sitaxsentan due to liver function test abnormalities (Q38386922)
Jump to navigation
Jump to search
scientific article published on 23 September 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Ambrisentan therapy in patients with pulmonary arterial hypertension who discontinued bosentan or sitaxsentan due to liver function test abnormalities |
scientific article published on 23 September 2008 |
Statements
1 reference
Ambrisentan therapy in patients with pulmonary arterial hypertension who discontinued bosentan or sitaxsentan due to liver function test abnormalities (English)
1 reference
Michael D McGoon
1 reference
Adaani E Frost
1 reference
Ronald J Oudiz
1 reference
David B Badesch
1 reference
Vallerie V McLaughlin
1 reference
Michael J Gerber
1 reference
Chris Dufton
1 reference
Darrin J Despain
1 reference
Lewis J Rubin
1 reference
23 September 2008
1 reference
Identifiers
1 reference